drugset / Trial / NCT02625519

Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)

NCT02625519

Phase 4 Unknown 180 enrolled Instituto Bernabeu
RandomizedParallel-groupOpen-labelTreatment

Summary

Exploratory, prospective, randomized, comparative, open trial with control group treated to assess whether the effective use of urinary FSH (uFSH) or recombinant FSH (rFSH) can be influenced by genotype of receptor N680S FSH Gene Polymorphism.

Timeline

Start
2015-12
Primary completion
2019-01
Completion
2019-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Bravelle Unknown 225 iu
Subject Gonal-f Protein / enzyme biologic 225 iu

Indications

No indication recorded.